CONMED Corporation (FRA:EC8)

Germany · Delayed Price · Currency is EUR

38.20

+0.60 (1.60%)

At close: Feb 20, 2026

-36.86% (1Y)

Market Cap	1.18B -46.2%
Revenue (ttm)	1.17B +5.2%
Net Income	40.08M -64.5%
EPS	1.29 -64.5%
Shares Out	n/a
PE Ratio	29.48
Forward PE	10.43
Dividend	0.53 (1.40%)
Ex-Dividend Date	Sep 15, 2025

Volume	n/a
Average Volume	1
Open	37.60
Previous Close	37.60
Day's Range	37.20 - 38.40
52-Week Range	30.00 - 60.50
Beta	n/a
RSI	66.35
Earnings Date	Jan 28, 2026

About CONMED

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems an... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1970

Employees 3,900

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol EC8

Full Company Profile

Financial Performance

In 2025, CONMED's revenue was $1.37 billion, an increase of 5.18% compared to the previous year's $1.31 billion. Earnings were $47.06 million, a decrease of -64.47%.

Financial numbers in USD Financial Statements